PL123449B1 - Process for preparing novel derivatives of 2-iminothiazoline - Google Patents

Process for preparing novel derivatives of 2-iminothiazoline Download PDF

Info

Publication number
PL123449B1
PL123449B1 PL1977223798A PL22379877A PL123449B1 PL 123449 B1 PL123449 B1 PL 123449B1 PL 1977223798 A PL1977223798 A PL 1977223798A PL 22379877 A PL22379877 A PL 22379877A PL 123449 B1 PL123449 B1 PL 123449B1
Authority
PL
Poland
Prior art keywords
formula
compound
optionally
alkyl
iminothiazoline
Prior art date
Application number
PL1977223798A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL123449B1 publication Critical patent/PL123449B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/43Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Claims (2)

1. Zastrzezenia patentowe 1. Sposób wytwarzania nowych pochodnych 2-iminoUazolilny o wzorze 1, ewentualnie w postaci jego farmaceutycznie dopuszczalnej soli, znamienny tym, ze zwiazek o wzorze 2 poddaje sie reakcji ze zwiazkiem o wzorze 3, w którym Y' oznacza grupe 10 wodorotlenowa, po czym otrzymany produkt ewen¬ tualnie przeprowadza sie w sól. 2. Sposób otrzymywania nowych pochodnych 2-imi-notiazoliny o wzorze 1, ewentualnie w postaci jego farmaceutycznie dopuszczalnej soli, znamienny tym, ze zwiazek o wzorze 2 poddaje sie reakcja ze zwiazkiem o wzorze Y-CO-CH2-CH2-CO-Y, w któ¬ rym Y oznacza atom chloru, grupe o wzorze 4, -N3, (alkil Ci_4)-0-COO-, -OCH2CN, podstawnik o wzorze 5, 6, 7, 8, 9 lub o wzorze -0-(alkil Ci_4), po czym otrzymany produkt ewentualnie przepro¬ wadza sie w sól. o o f =N-CCH2CI-UC-N=($1 I I CH3 CH3 WZÓR \ r~S CN=NH ^ CK 3 WZÓR 2 a 0 o ri_ » if l L 2 CH3 WZÓR 3123 449 N02^0^~ ° " WZÓR 4 F F F F W20R 5 H OH oV4n OPh WZÓR S O-C \ NH N(GK alkil)2 WZÓR 8 O-C \ CH: 0[CHalkil)2 WZÓR 9 L 632594 O 100 200300 400 500600700800 pg. proteiny enzymu 2 ™ 80.000 60.000 2: ¦o o c ? » ^c o o c N O » O a o. tn * c 'a "o o. u» c h- Zt. o "o* a *^ i ^r A0.0C0 h 20.000 2 godz. &% 3godz 7 godz. 52% 51% 85% BW 36% 54% 53% 55% 8,1 8,1 12,5 25 25 25 68 68 63 Dawka doustna (mg/kg) * 1 królik /grupe Fig.l Fig.
2. PL PL PL
PL1977223798A 1976-05-03 1977-04-30 Process for preparing novel derivatives of 2-iminothiazoline PL123449B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68287676A 1976-05-03 1976-05-03

Publications (1)

Publication Number Publication Date
PL123449B1 true PL123449B1 (en) 1982-10-30

Family

ID=24741558

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977223798A PL123449B1 (en) 1976-05-03 1977-04-30 Process for preparing novel derivatives of 2-iminothiazoline

Country Status (24)

Country Link
JP (1) JPS52133981A (pl)
AU (1) AU508889B2 (pl)
BE (1) BE854172A (pl)
CA (1) CA1078846A (pl)
CH (1) CH629490A5 (pl)
DE (1) DE2719577A1 (pl)
DK (1) DK173777A (pl)
ES (2) ES458237A1 (pl)
FI (1) FI771285A (pl)
FR (1) FR2350351A1 (pl)
GB (1) GB1534242A (pl)
HU (1) HU180504B (pl)
IE (1) IE46011B1 (pl)
IL (1) IL51935A (pl)
IT (1) IT1082657B (pl)
LU (1) LU77243A1 (pl)
NL (1) NL7704322A (pl)
NO (1) NO146061C (pl)
NZ (1) NZ183941A (pl)
PH (1) PH14030A (pl)
PL (1) PL123449B1 (pl)
SE (1) SE7704594L (pl)
YU (1) YU111677A (pl)
ZA (1) ZA772614B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US5555162A (en) * 1994-04-26 1996-09-10 Sylvan R. Shemitz Designs, Inc. Compact fluorescent luminaire
USRE37310E1 (en) 1994-12-06 2001-08-07 Sylvan R. Shemitz Designs, Inc. Compact fluorescent luminaire
FR2748023B1 (fr) 1996-04-30 1998-07-24 Rhone Poulenc Chimie Hydrogenofluorosulfonates de base organique, leur utilisation pour liberer les bases organiques de leur fluorhydrate, leur procede de preparation, compositions les comportant

Also Published As

Publication number Publication date
FI771285A (pl) 1977-11-04
BE854172A (fr) 1977-11-03
YU111677A (en) 1983-01-21
AU508889B2 (en) 1980-04-03
PH14030A (en) 1980-12-12
ES458237A1 (es) 1978-07-01
FR2350351A1 (fr) 1977-12-02
DE2719577A1 (de) 1977-11-24
IE46011B1 (en) 1983-01-26
IE46011L (en) 1977-11-03
IL51935A0 (en) 1977-06-30
NO146061B (no) 1982-04-13
NO771375L (no) 1977-11-04
LU77243A1 (pl) 1977-12-13
SE7704594L (sv) 1977-11-04
DK173777A (da) 1977-11-04
NL7704322A (nl) 1977-11-07
IL51935A (en) 1981-07-31
IT1082657B (it) 1985-05-21
JPS52133981A (en) 1977-11-09
AU2463077A (en) 1978-11-02
NO146061C (no) 1982-07-28
ZA772614B (en) 1978-12-27
HU180504B (en) 1983-03-28
NZ183941A (en) 1980-12-19
ES468377A1 (es) 1978-12-16
CH629490A5 (en) 1982-04-30
CA1078846A (en) 1980-06-03
FR2350351B1 (pl) 1979-03-02
GB1534242A (en) 1978-11-29

Similar Documents

Publication Publication Date Title
NO167741C (no) Analogifremgangsmaate for fremstilling av terapeutiske rebeccamycinanaloger.
AU6128590A (en) Novel compounds
DE3854410D1 (de) 3-Alkoxy-2-hydroxypropylcellulosederivate und ihre Verwendung in Baumaterialien.
IE822467L (en) Imidazole derivatives
ATE216375T1 (de) Aminothiazole derivate, ihre herstellung und sie enthaltenden pharmazeutischen zusammensetzungen
ES8302001A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
IE883453L (en) Ergoline derivatives
PL123449B1 (en) Process for preparing novel derivatives of 2-iminothiazoline
GB1434323A (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
ES8607311A1 (es) Un procedimiento para la preparacion de compuestos aminoheterociclicos.
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
IE800834L (en) 7-n-heterocyclyl cephalosporins
IE44184L (en) Imidazole derivatives
EP0363107A3 (en) Tri-nuclear dyes for photographic compositions and method of preparation
ES8609330A1 (es) Un procedimiento para preparar nuevos derivados de 1,3-dihi-dro-6-1-ciano-1-isopropil-n-fenetil-n-metil-omega-aminoal- quil-7--hidroxi-furo-(3,4-c)-piridina
ES476529A1 (es) Procedimiento para la obtencion de derivados de 3-aminopro- poxiarilo.
GB1481147A (en) 3-methyl-pyrazole-5-carboxylates
GB8515212D0 (en) Thiazolidine derivatives
HUT45059A (en) Process for producing abeoergoline derivatives
ES8203328A1 (es) Un procedimiento para la preparacion de 6-fluordihidroxifenilalaninas.
IE43972L (en) Piperidinoalkylindole derivatives
ES481188A1 (es) Un procedimiento para preparar aminoalcohiltiodibenzotiepi- nas.
ES8105749A3 (es) Procedimiento para la preparacion de nuevos derivados inosi-na
JPS54106500A (en) 3-sulforifamycin and its preparation